China and India are the leading exporters of 3-benzyl-6-bromo-2-methoxyquinoline, collectively accounting for the majority of global shipments, while the United States, Germany, and Japan represent the largest importers. Trade volumes remain concentrated among a small group of high-income and pharmaceutical-manufacturing nations. Recent data shows stable export volumes from China alongside modest growth in Indian exports, with 3-benzyl-6-bromo-2-methoxyquinoline prices remaining relatively flat amid consistent demand from R&D-intensive markets.
Recent Commodity Market Intelligence
1. **Price Trends**
- **Domestic Market**: The price of 3-benzyl-6-bromo-2-methoxyquinoline has recently shown slight fluctuations, with mainstream transaction prices in the range of 1,200-1,350 RMB/kg, representing an increase of approximately 3%-5% compared to last month.
- **International Market**: Prices in Europe and the US remain stable at USD 180-200/kg. Prices in Asian markets (India, Japan) are slightly lower, around USD 160-175/kg. Import landed prices have risen slightly due to increased logistics costs.
2. **Supply and Demand**
- **Supply Side**: Major domestic producers (such as a certain chemical enterprise in Zhejiang and a certain biotech company in Jiangsu) maintain operating rates above 80%. However, affected by environmental protection policies, some small and medium-sized manufacturers have reduced production. Overall supply has increased by approximately 5% month-on-month but remains below the same period last year.
- **Demand Side**: Demand for downstream pharmaceutical intermediates (such as anti-cancer drug synthesis) remains stable, while demand in the agricultural intermediate sector has grown slightly. Export orders (primarily to Europe and the US) have increased to 40% of the total, driving a month-on-month increase of 8% in total demand.
3. **Cost and Profit**
- **Raw Material Costs**: Prices for key raw materials such as benzylamine and bromine have remained relatively stable recently. However, costs for methoxy compounds have risen by approximately 2% due to energy price fluctuations, providing significant support to overall costs.
- **Profit Margins**: The industry's average gross margin remains at 25%-30%, unchanged from last month. However, small and medium-sized manufacturers have seen their margins compressed to around 20% due to increased environmental protection investments.
4. **Inventory and Logistics**
- **Inventory Levels**: Inventory turnover days for major domestic manufacturers have shortened to 15-20 days. Trader inventories are low, leading to increased willingness to restock.
- **Logistics Impact**: Rising sea freight costs have increased import costs, but domestic logistics remain smooth, with no significant obstacles to supply.
5. **Policy and Industry Developments**
- **Environmental Policies**: Multiple regions have strengthened supervision of chemical parks, leading to production halts for maintenance at some enterprises, tightening short-term supply.
- **Industry News**: A certain international pharmaceutical company has announced plans to increase procurement of this product's intermediates, with expected future demand growth of 10%-15%.
Analysis and Judgment
1. **Price Support Factors**: Stable downstream pharmaceutical demand, increased export orders, rising raw material costs, and environmental production restrictions collectively support prices.
2. **Price Suppression Factors**: Intense competition in international markets and the potential risk of low-price dumping due to compressed margins for small and medium-sized manufacturers.
3. **Short-term Trend**: Prices are expected to remain high with fluctuations, within a range of 1,250-1,400 RMB/kg (domestic). International markets may see slight adjustments influenced by exchange rates.
Forecast
1. **Next 1-2 Months**: Driven by peak demand in the pharmaceutical industry, prices may rise slightly to 1,350-1,450 RMB/kg. However, caution is needed regarding the risk of supply surges if environmental policies are relaxed.
2. **Next 3-6 Months**: If downstream pharmaceutical intermediate demand remains robust, prices could break through 1,500 RMB/kg. If international competition intensifies or raw material costs decline, prices may correct to 1,200-1,300 RMB/kg.
3. **Risk Warnings**: Attention should be paid to the enforcement intensity of environmental policies, changes in international sea freight costs, and fluctuations in downstream industry demand.
3-Benzyl-6-bromo-2-methoxyquinoline is a white to off-white crystalline solid at room temperature, typically odorless and non-volatile, with a melting point commonly reported between 118–122 °C. It is an aromatic heterocyclic compound classified as a functionalized quinoline derivative and serves primarily as a specialty organic intermediate. Its structural features—bromine at C6, methoxy at C2, and benzyl at C3—enable selective cross-coupling, nucleophilic substitution, and cyclization reactions in multi-step syntheses. It is employed predominantly in the development and manufacture of pharmaceutical candidates and agrochemical actives, particularly in programs targeting kinase inhibitors and crop protection agents.
3-benzyl-6-bromo-2-methoxyquinoline is a reactant used in the preparation of Bedaquiline (B119550), a potential drug in the treatment of tuberculosis. 3-benzyl-6-bromo-2-methoxyquinolineSupplier
White Solid
This chemical is included in Fine Chemicals. See more about what is 3-benzyl-6-bromo-2-methoxyquinoline and 3-benzyl-6-bromo-2-methoxyquinoline SDS information.
Find 3-benzyl-6-bromo-2-methoxyquinoline supply and 3-benzyl-6-bromo-2-methoxyquinoline suppliers on Guidechem to meet your sourcing needs from 120 trusted and certifedsuppliers.
Guidechem assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness, fitness for purpose or timeliness.